MedGenome has announced a majority investment in Mumbai-headquartered Medcare Management Services, a radiology and nuclear medicine provider specialising in PET-CT and molecular imaging services.
Medcare was founded in 2012 by Dr Atul Marwah, a nuclear medicine specialist, and Dr Ruchira Marwah, a radiologist. The company operates four imaging facilities in Chembur, Goregaon, Andheri and Navi Mumbai. Its services include PET-CT, CT, mammography, nuclear medicine scans and theragnostic facilities. Over the past decade, Medcare has partnered with more than 50 hospitals and physicians across Mumbai.
Dr Amit Kakar, Managing Partner and Head of Asia at Novo Holdings, and Chairman of the Board of MedGenome, said, “MedGenome’s investment in Medcare marks an important step in strengthening its vision of building an integrated diagnostics ecosystem for India. By bringing together Medcare’s imaging and pathology expertise with MedGenome’s leadership in multi-omics, this partnership expands access to earlier and more precise diagnostics for patients. As an investor, Novo Holdings is pleased to support this next phase of growth as the company continues advancing high-quality, science-led healthcare.”
Surajit Chakrabartty, CFO of MedGenome, said, “Integrating Medcare with MedGenome further strengthens our presence in western India and aligns with our long-term vision of building a unified, integrated diagnostics ecosystem. Diagnostics is the critical starting point in disease management. As leaders in omics-led diagnostics, this strengthens our ability to deliver comprehensive, end-to-end solutions across the patient journey. Our mission has been to improve early and accurate diagnosis and targeted treatment, making affordable precision healthcare accessible to patients across the country, and we will continue to work towards this with like-minded partners.”
The companies stated that nuclear medicine plays a role in oncology, cardiology and neurology for diagnosis and treatment planning. PET-CT imaging, combined with genetic tests, supports cancer detection and influences treatment and monitoring.
Dr Atul Marwah, Founder, Medcare, said, “For over a decade, Medcare has been committed to delivering high-quality, accessible radiology and nuclear medicine services to patients across Mumbai. As a part of MedGenome, Medcare can unlock significant growth opportunities, enabling us to offer integrated imaging, pathology, and genomics solutions, which are especially critical in oncology and the management of complex diseases. We’re excited to continue leading Medcare into its next phase of expansion.”
MedGenome stated that the collaboration supports its strategy to build an integrated diagnostics platform with a focus on multi-omics by strengthening its capabilities across radiology, pathology and genomics and expanding access to precision diagnostics across India.